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China has the largest plateau, Qinghai-Tibet Plateau, where inhabited the most high altitude populations. Moreover,
millions of people from plain areas come to the plateau for travel and work purposes and the number of the
newcomers has been increasing every year. The hypoxic environment of plateau raised a series of related health
issues in the new immigrants, so have created a special medical discipline - High Altitude Medicine. Over the past
decades, researches on high altitude medicine have never being ceased in China, and lots of research findings have
been reported. Application and practice of these achievements have greatly decreased the mobility and mortality
of high-altitude diseases, however, there remained lots of questions to be elucidated. In view of this, the authors
were granted a special project from the National Health and Family Planning Commission of China, and conducted
a multi-center, prospective, on-scene high altitude medicine study for the acute mountain sickness. Some innovative
findings were achieved, and the parameters for diagnosis and application conditions were proposed. Furthermore, the
different diagnoses and treatment effects were compared, and a more standardized, reasonable scheme was drawn
up. Regarding the unbalanced medical resources in the vast high altitude area, an application system for the public
and the army has been established. In the 21st century, innovations in China and novel research approaches have
provided great opportunities for the development of high altitude medicine. It is believed that the researchers in China
are able to catch the opportunities and address the challenges.
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highest in the world, is located in western China. It is
also the home of the largest high-altitude population
with a long history. Due to the special and unique envir-
onment, its inhabitants have been subjected to physical
and psychological challenges. The health problems asso-
ciated with the exposure to high altitude have long been
observed by the local Chinese, mainly the Tibetan and
Han populations. Meanwhile, many preventative mea-
sures and therapies were developed sporadically. The in-
vestigation of high altitude medicine was only initiated
after the peaceful liberation of Tibet in 1951. Some of
the findings were well accepted by the entire nation and
the world.
As part of this investigation, Xinqiao Hospital has
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unless otherwise stated.hospital and sent to march to Tibet decades ago. Over
the past decades, the impacts of acute exposure to high
altitude on the physiological responses, psychological
changes, metabolic shifts, pathological changes and dis-
ease status changes have been systemically investigated
[1]. Many proceedings have been reported in China. For
the first time, high altitude pulmonary edema was identi-
fied. In addition, the types of acute and chronic high alti-
tude diseases were classified [2]. The clinical symptoms
and signs were identified, and the diagnostic criteria
were described [3]. The corresponding therapies for
these diseases were also described [4]. Meanwhile, the
mechanism responsible for hypoxic pulmonary arterial
hypertension was illustrated [5,6]. Overall, much re-
search on the molecular basis and clinical efficacy was
well-established after decades of exploration [7,8]. As a
consequence, these achievements have led to decreased
incidence and severity of high altitude-associated dis-
eases. The work of other groups has also placed focus
on high altitude medicine, which has benefited clinicalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Huang Military Medical Research 2014, 1:17 Page 2 of 4
http://www.mmrjournal.org/content/1/1/17and basic research in China [9]. Undeniably, China has
become a beacon in the field of high altitude research
throughout the world.
Currently, the progress in high altitude medicine has
facilitated the move of plains residents to high altitude
plateaus. As a good example, the Tibet railway was suc-
cessfully constructed with few health consequences; this
was made possible by the contributions of Chinese high
altitude medial service providers with their cutting-edge
expertise [10-12].
Although such progress has significantly ameliorated
the problems associated with rapidly ascending to high
altitudes from the plains, minimizing the adversity asso-
ciated with high altitude diseases remains a problem, es-
pecially when large groups are required to ascend to high
altitude and perform efficiently in cases such as humani-
tarian rescue missions after an earthquake. Currently, the
international Lake Louise criteria for diagnosing acute
high altitude disease differ from China’s criteria [13-15].
The majority of the Chinese experience with high altitude
medicine has not been well recognized by the inter-
national community. This confusion has resulted in a cha-
otic state associated with the diagnosis and treatment of
high altitude diseases to some extent. Due to the lack of
unified guidelines, clinicians vary greatly in their ap-
proaches to treating severe acute high altitude diseases.
All these phenomena reflect the underdevelopment of
high altitude medicine, which cannot meet the demands
of the great number of residents in this vast area.
Over the past decades, as economic development has
progressed, the population ascending to the high altitude
plateau has increased markedly, and human activities
and boundaries have gradually been extended. The un-
balanced high altitude medical resource configuration
did not adapt to the changing situation, which requir-
ed the further development of high altitude medicine.
Meanwhile, several factors have provided unprecedented
opportunities for high altitude medicine, including im-
provements in innovation in China, evidence-based medi-
cine, and translational medicine [16]. In this context, we
were granted a special project from the Health Ministry
(currently named the National Health and Family Plan-
ning Commission of China), and we performed a multi-
center, prospective, on-scene high altitude medicine
study with many aims, including the establishment of
acute high altitude disease alert systems, transformation
of our experience-based medicine into evidence-based
clinical trials to standardize the identification of high
altitude diseases and the application of well-developed
techniques to the prevention and treatment of various
high altitude diseases [17-19].
In our studies, we discovered some innovative findings
regarding some of our objectives, suggesting parameters
for diagnosis and application conditions. Furthermore,we compared different diagnoses and treatments and pro-
posed a more standardized, reasonable scheme. Regarding
the unbalanced medical resources associated with this vast
high altitude area, we established an application system
for the public and the army. Many challenges lie ahead
and should be faced and dealt with to strengthen high alti-
tude medicine research in China.
The diagnostic criteria differ between China and Western
countries. We compared the Chinese criteria and the Lake
Louise Consensus, which is widely used in the West. The
same groups of participants exposed to rapid high altitude
ascension were individually evaluated by these two systems.
The results showed that the participants who were diag-
nosed as having acute high altitude sickness according to
the Lake Louise criteria also met the diagnostic criteria of
China. However, not all high altitude sickness patients di-
agnosed by the Chinese criteria were considered to have
acute high altitude sickness according to the Lake Louise
criteria [18]. Thus, the Lake Louise Consensus appears to
have relatively lower sensitivity compared with the Chinese
criteria. From another perspective, more false positives
might be produced by the Chinese diagnostic criteria com-
pared with the Lake Louise criteria. The conflict between
these two criteria creates a dilemma for clinicians in
China. The Lake Louise Consensus is well accepted by
the international community, which might confuse the
interpretation of reports on high altitude sickness from
China [14]. Furthermore, the presence of two different
criteria increases the heterogeneity among clinical stud-
ies and increases the difficulty associated with perform-
ing large, multi-site acute high altitude sickness clinical
trials. These issues eliminate most Chinese studies, and
the paucity of the data produced by Chinese researchers
also causes the high altitude sickness results to be less rep-
resentative, considering the weight of China’s high altitude
population and area.
In addition, evidence-based medical studies are limited
by a non-linear complex model. Some other affecting
factors include the following: geographical area, terrain,
geomorphology, climate, weather, sub-environment, par-
ticipant variables, high altitude exposure categories, dur-
ation, acclimatization-adaption types and pre-medication
[13]. On-site research also differs from research utilizing
hypobaric chambers or other laboratory simulation
conditions. All these variables should be considered to
minimize any biases and to facilitate the acquisition of
more convincing and objective conclusions. It remains
unclear how these variables can be reconciled under the
principles of evidence-based medicine in real-world
studies. Therefore, maintaining the efficacy of the evidence
while minimizing the noise signals from other variables re-
mains a priority in evidence-based medicine-guided trials.
In our study, we covered a wide range of ascensions to
the high altitude plateau, which were not limited to
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high as 4,500 m were also investigated, which revealed
new effects associated with higher altitude exposure as
the body became more hypoxic and the symptoms of
acute high altitude sickness developed. Intriguingly, this
type of ascension cannot be categorized as acute high
altitude sickness, although the hypoxic symptoms are
similar. Undoubtedly, this situation leads to an even
worse hypoxic status. The precise effects of this type of
high altitude exposure remain elusive. Nonetheless, this
phenomenon is important because high altitude opera-
tions and construction are common.
The high altitude sickness diagnostic criteria used in
China differ from the Lake Louise Consensus, which is
used in Western countries. Regardless of these distinc-
tions, both sets of criteria adopt complaints as the indi-
ces used to diagnose acute high altitude sickness. The
caveat is that these evaluation systems are based on sub-
jective complaints rather than objective indices. The
identification of severe acute high altitude sickness before
the presented clinical symptoms remains a challenge.
Considering the on-site conditions, tight cooperation be-
tween researchers and clinicians is necessary to apply the
techniques used in high altitude medicine research to clin-
ical practice. Current high altitude sickness therapy has
already reduced its morbidity and mortality and improved
its prognosis. However, the effects greatly differ among
different facilities. Evidence-based medicine is an emer-
ging strategy that emphasizes clinical evidence, which
serves as a solid and more convincing guide for clinical
practice and leads to better prognoses and fewer side ef-
fects. Different degrees of recommendations based on the
rank of the evidence also promote the widespread use of
clinical guidelines and consensus. Introducing this con-
cept into high altitude sickness might provide a new plat-
form to further its research. Guided by evidence-based
medicine and combined with newly developed clinical
techniques, research on high altitude sickness might ad-
vance further. With respect to China’s transitional and
empirical methods, some evidence-based advancements
should be expected in the near future. Importantly, the co-
operation among the sanitary administration, research
groups and clinical facilities is critical for the success of
these developments. Together, future successful clinical
investigations on high altitude sickness require most, if
not all, of the following conditions: patient-benefitting
moral principles, evidence-based medical guidelines, ease
of implementation in the plateau region, and cooperation
among different groups.
In this century, it can be foreseen that the population as-
cending to the plateau will increase and that the extent of
human activity will be extended remarkably. Hopefully, re-
search on high altitude medicine in China will blossom
based on previous achievements. The introduction ofevidence-based medicine and translational medicine might
accelerate the development of high altitude medicine in
China. Additionally, high altitude medicine fellows in China
might contribute more to the world.
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